Recently, in late august 2025, the European Society of Cardiology released a Clinical Consensus Statement on mental health and cardiovascular disease, considering the complex interactions between the psychological status or the mental illness and the cardiovascular diseases. This Consensus Statement introduces the concept of Psycho-Cardio Team, composed by cardiovascular specialists, mental health professionals, nurses, primary care team, social workers, other allied professionals, working together to ensure an integrated care1. The group of authors suggest some recommendations to improve the mental health of patients with cardiovascular diseases: during the cardiovascular visits the patients must be checked for symptoms of psychiatric diseases and also, during the psychiatry evaluations, the patients must be checked for cardiovascular risk factors, using validated tools for screening and diagnosis1. The cardiovascular care must integrate mental health care, especially in patients at risk. The best approach of communication with patients with cardiovascular diseases, to improve mental health and resilience, remains to be determined. Multiple studies have determined that a positive mental health, including optimism, happiness, and high life satisfaction, is associated with a lower cardiovascular risk. Vice versa, social isolation, financial or work pressures, depression, anxiety, and posttraumatic stress disorder lead to a higher risk for cardiovascular diseases, such as hypertension, coronary artery disease (including myocardial infarction), cerebrovascular disease, peripheral artery disease, atrial fibrillation, ventricular arrhythmias, sudden cardiac death, chronic heart failure. However, depression and anxiety can be ignored in routine cardiovascular practice and considered the normal reaction of individuals to their prognostic burden of disease. Approximately 72% of patients with chronic heart failure present anxiety, women having even higher percentages2. Also, the prevalence of anxiety in patients with atrial fibrillation is 28%3. A systematic review showed a prevalence of chronic stress (defined as physical and emotional imbalance) of 58% in patients with cardiovascular diseases4. The most used screening tools for anxiety and depression are the Whooley questions, the Patient Health Questionnaire (PHQ)-2 and the Generalized Anxiety Disorder (GAD)-25-7.
In patients with severe mental illness the cardiovascular diseases have a multifactorial etiology, related to unhealthy lifestyle, obesity, sedentarism, dyslipidemia, smoking, diabetes etc. The cardiovascular risk associated to some psychiatric drugs must not be ignored, therefore the Consensus Statement recommends monitoring the electrocardiogram after the initiation of an antipsychotic drug at week 1, 6, 12, then every year1. Special attention must be accorded to treatment with olanzapine, quetiapine, risperidone, sertindole, amisulpride, ziprasidone. The lowest effective dose must be used and always special caution when new drug is initiated, checking for drug interactions. Treatment optimizations include monotherapy, selection of medication less likely to induce weight gain or other cardiovascular risks, a strict monitoring of the patient for drug interactions and possible side effects. Antidepressant therapy is recommended only for moderate to severe anxiety disorders and depression. Benzodiazepines as first-line therapy should be avoided. In patients with heart failure the antidepressants must be avoided, except in severe depression, when the risks associated with untreated depression outweigh the risks1. Antidepressants with a risk to prolong the QTc interval (citalopram, escitalopram more than 20 mg/day) must be replaced with newer antidepressants, which have a better safety profile1.
The Consensus Statement offers recommendations regarding special categories of patients: women, elderly patients, patients with cancer or cancer survivors, migrants and refugees, people with frailty and multimorbidity1. The stigma of mental illnesses in the population must be addressed, to decrease its impact on cardiovascular healthcare, that must use an integrated approach.
“No conflicts of interest”
Address for correspondence:
Camelia C. DIACONU
E-mail: drcameliadiaconu@gmail.com